Connecting Minds from Across the Globe
As the most common cancer in women worldwide and the second most common cancer overall, breast cancer remains a fact of life. Read more
As the most common cancer in women worldwide and the second most common cancer overall, breast cancer remains a fact of life. Read more
Since the late 1970s, clinicians have distinguished breast cancers types according to the presence or absence of certain receptors that sit on the surface of these tumor cells. Depending on the receptors found—namely, the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2)—a doctor can get a better sense of the prognosis and which treatments might work. Read more
People can be forgiven for thinking that the messages coming out of the American Association for Cancer Research annual meeting in Chicago this week seem to conflict. Finishing up today, the meeting hosted just shy of 17,000 scientists, exhibitors and guests and had several talks expounding the dizzying pace of genome technologies being applied to cancer diagnosis and treatment. At the same time, some speakers warned of the challenges inherent in doing cancer ‘omics.’ … Read more
Personal genomics company 23andMe and biotechnology firm Genentech are recruiting breast cancer patients to study genetic predictors of how well they respond to the drug Avastin. Read more
Ruthann Rudel walks up to the shelf in a Cambridge CVS and picks up an “Arm and Hammer Essential Naturals” deodorant stick . The bright yellow package has jaunty lettering and a green leaf on the label and announces that it offers “Aluminum Free — Paraben Free Natural Protection.” … Read more